Nevus, Pigmented  >>  Genasense (oblimersen)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Genasense (oblimersen) / Genta
NCT00016263: Dacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant Melanoma

Completed
3
US
oblimersen sodium, dacarbazine
Genta Incorporated
Melanoma (Skin)
 
12/04
AGENDA, NCT00518895 / 2007-003340-30: Trial of Dacarbazine With or Without Genasense in Advanced Melanoma

Checkmark P3 data (Adv melanoma) AGENDA
May 2011 - May 2011: P3 data (Adv melanoma) AGENDA
Checkmark P3 data (Adv melanoma) AGENDA
May 2011 - May 2011: P3 data (Adv melanoma) AGENDA
Completed
3
300
US, Canada, Europe, RoW
dacarbazine plus Genasense, dacarbazine plus Genasense (oblimersen, G3139), dacarbazine plus placebo, dacarbazine plus placebo (0.9% Sodium Chloride Injection)
Genta Incorporated
Melanoma
05/11
05/11
NCT00543205: Pharmacokinetics of G3139 in Subjects With Advanced Melanoma, Including Those With Normal Hepatic Function and Those With Moderate Hepatic Impairment

Terminated
2/3
6
US
Genasense® (G3139, oblimersen sodium), G3139, Oblimersen, Oblimersen sodium
Genta Incorporated
Advanced Melanoma and Normal or Impaired, Hepatic Function
05/07
05/07

Download Options